DCOY (Decoy Therapeutics Inc. Common Stock) Stock Analysis - SEC Filings

Decoy Therapeutics Inc. Common Stock (DCOY) is a publicly traded the market company. As of May 21, 2026, DCOY trades at $5.56 with a market cap of $2.47M and a P/E ratio of 0.00. DCOY moved +3.49% today. Year to date, DCOY is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $4.32 to $16.92. Rallies surfaces DCOY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find DCOY SEC filings?

Rallies organizes DCOY SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

DCOY Key Metrics

Key financial metrics for DCOY
MetricValue
Price$5.56
Market Cap$2.47M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$16.92
52-Week Low$4.32
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest DCOY News

DCOY Analyst Consensus

DCOY analyst coverage data. Average price target: $0.00.

Common questions about DCOY

Where can I find DCOY SEC filings?
Rallies organizes DCOY SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show DCOY 10-K and 10-Q filings?
Rallies organizes DCOY SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is DCOY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for DCOY. It does not provide personalized investment advice.
DCOY

DCOY